We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$272M
AUM Growth
+$26.7M
Cap. Flow
+$18.7M
Cap. Flow %
6.88%
Top 10 Hldgs %
64.63%
Holding
780
New
77
Increased
155
Reduced
96
Closed
42
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEXEA
651
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$1K ﹤0.01%
14
GM.WS.B
652
DELISTED
General Motors Company
GM.WS.B
$1K ﹤0.01%
47
FTR
653
DELISTED
Frontier Communications Corp.
FTR
$1K ﹤0.01%
211
+186
+744% +$1.02K
SHPG
654
DELISTED
Shire pic
SHPG
$1K ﹤0.01%
5
ACN icon
655
Accenture
ACN
$88.5B
-6
Closed -$1K
ALKS icon
656
Alkermes
ALKS
$8.66B
$0 ﹤0.01%
2
AMD icon
657
Advanced Micro Devices
AMD
$817B
$0 ﹤0.01%
+1
New +$23
AMRN
658
Amarin Corp
AMRN
$297M
-30
Closed -$2K
AOM icon
659
iShares Core Moderate Allocation ETF
AOM
$1.77B
$0 ﹤0.01%
+4
New +$151
AOR icon
660
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.65B
$0 ﹤0.01%
+4
New +$179
ASIX icon
661
AdvanSix
ASIX
$560M
$0 ﹤0.01%
15
BHE icon
662
Benchmark Electronics
BHE
$2.78B
$0 ﹤0.01%
16
BLRX
663
BioLineRX
BLRX
$13M
-6
Closed -$3K
BWX icon
664
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.34B
-32
Closed -$1K
CHTR icon
665
Charter Communications
CHTR
$16.4B
-3
Closed -$1K
CIVI
666
DELISTED
Civitas Resources
CIVI
-5
Closed
CLDX icon
667
Celldex Therapeutics
CLDX
$2.78B
$0 ﹤0.01%
3
COST icon
668
Costco
COST
$419B
$0 ﹤0.01%
2
-38
-95% -$8.56K
CRIS icon
669
Curis
CRIS
$9.71M
0
CTXR icon
670
Citius Pharmaceuticals
CTXR
$14M
0
CVS icon
671
CVS Health
CVS
$136B
$0 ﹤0.01%
2
DBO icon
672
Invesco DB Oil Fund
DBO
$371M
-10
Closed
DFE icon
673
WisdomTree Europe SmallCap Dividend Fund
DFE
$163M
-300
Closed -$20K
DGX icon
674
Quest Diagnostics
DGX
$23.2B
$0 ﹤0.01%
2
DOC icon
675
Healthpeak Properties
DOC
$15.4B
$0 ﹤0.01%
14
-27
-66% -$710

Similar funds

McAdam LLC's Q3 2018 Portfolio in Review

As of Q3 2018, McAdam LLC held 780 positions worth $272M, up 11% from $246M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $18.7M of net new capital in Q3 2018, opening 77 new positions and adding to 155 existing holdings. Its largest new stake was State Street SPDR MSCI EAFE StrategicFactors ETF: 4,880 shares worth $311K.

By sector, the portfolio is most concentrated in Healthcare at 1.5% of assets, up from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was IBM, an estimated $374K trimmed.

  • McAdam LLC's largest Q3 2018 buy was State Street SPDR MSCI EAFE StrategicFactors ETF: 4,880 shares worth $311K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q3 2018, an estimated $1.87M increase.
  • McAdam LLC's biggest Q3 2018 reduction was IBM, cutting an estimated $374K.
  • McAdam LLC fully exited Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q3 2018, selling an estimated $239K.
  • McAdam LLC's ten largest holdings make up 65% of its $272M portfolio in Q3 2018.
  • McAdam LLC opened 77 new positions and closed 42 in Q3 2018.
  • McAdam LLC's portfolio value rose 11% quarter-over-quarter to $272M.

Based on McAdam LLC's 13F filing for Q3 2018, filed 10 Oct 2018.